Penumbra Inc

PEN: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|&bLOCK|&^BLOCK|QvL!mgV

Penumbra and Boston: Penumbra to Benefit from Impending Acquisition by Boston Scientific

Boston Scientific announced its impending acquisition of Penumbra for roughly $14.5 billion, which translates into $374 per share, to be financed by a combination of Boston's cash and shares.

Sponsor Center